Effect of Polydeoxyribonucleotide on Angiogenesis and Wound Healing in an Model of Osteoarthritis

Osteoarthritis (OA) is degenerative disease, leading to pain and functional disability. It is reported that polydeoxyribonucleotide (PDRN) is a suitable therapy for OA. However, the therapeutic mechanisms of PDRN in OA are not fully understood. To investigate the effect of PDRN in an in vitro model...

Full description

Bibliographic Details
Main Authors: Ahreum Baek, Yoon Kim, Jin Woo Lee, Sang Chul Lee, Sung-Rae Cho
Format: Article
Language:English
Published: SAGE Publishing 2018-11-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/0963689718804130
_version_ 1818402281537667072
author Ahreum Baek
Yoon Kim
Jin Woo Lee
Sang Chul Lee
Sung-Rae Cho
author_facet Ahreum Baek
Yoon Kim
Jin Woo Lee
Sang Chul Lee
Sung-Rae Cho
author_sort Ahreum Baek
collection DOAJ
description Osteoarthritis (OA) is degenerative disease, leading to pain and functional disability. It is reported that polydeoxyribonucleotide (PDRN) is a suitable therapy for OA. However, the therapeutic mechanisms of PDRN in OA are not fully understood. To investigate the effect of PDRN in an in vitro model of OA, interleukin (IL)-1β or phosphate-buffered saline (PBS) was used to treat a human chondrocytic cell line in hypoxic conditions for 24 h (IL-1β group or control group). PDRN was then used to treat IL-1β group cells for 24 h (PDRN group). By Label-Based Human Antibody Array 1000, angiopoietin-2 (ANG-2), platelet-derived growth factor (PDGF), angiostatin, and endostatin, which were related to angiogenesis, were chosen for further validation studies. Quantitative real-time reverse transcription polymerase chain reaction and western blot analysis validated that the levels of PDGF and ANG-2, which were related to pro-angiogenesis, were significantly increased in the PDRN group compared with those in the control group or the IL-1β group. However, the levels of endostatin and angiostatin, which were related in anti-angiogenesis, were significantly decreased in the PDRN group compared with those in the control group or the IL-1β group. In the same manner, vascular endothelial growth factor, which was a mediator of angiogenesis, was significantly increased in the PDRN group compared with those in the control group or the IL-1β group. Furthermore, wound closure was significantly increased in the PDRN group compared with the control group or the IL-1β group by in vitro scratch assay. Moreover, PDRN decreased expression of metalloproteinase 13, as a catabolic factor for OA, but increased expression of aggrecan, which was an anabolic factor for OA. These data suggest that PDRN may promote angiogenesis and wound healing via down-regulation of catabolism and up-regulation of anabolism in an in vitro model of OA.
first_indexed 2024-12-14T08:05:52Z
format Article
id doaj.art-059a68f8d076465d87df6fa368e1d91c
institution Directory Open Access Journal
issn 0963-6897
1555-3892
language English
last_indexed 2024-12-14T08:05:52Z
publishDate 2018-11-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-059a68f8d076465d87df6fa368e1d91c2022-12-21T23:10:12ZengSAGE PublishingCell Transplantation0963-68971555-38922018-11-012710.1177/0963689718804130Effect of Polydeoxyribonucleotide on Angiogenesis and Wound Healing in an Model of OsteoarthritisAhreum Baek0Yoon Kim1Jin Woo Lee2Sang Chul Lee3Sung-Rae Cho4 Department of Rehabilitation Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul, South KoreaOsteoarthritis (OA) is degenerative disease, leading to pain and functional disability. It is reported that polydeoxyribonucleotide (PDRN) is a suitable therapy for OA. However, the therapeutic mechanisms of PDRN in OA are not fully understood. To investigate the effect of PDRN in an in vitro model of OA, interleukin (IL)-1β or phosphate-buffered saline (PBS) was used to treat a human chondrocytic cell line in hypoxic conditions for 24 h (IL-1β group or control group). PDRN was then used to treat IL-1β group cells for 24 h (PDRN group). By Label-Based Human Antibody Array 1000, angiopoietin-2 (ANG-2), platelet-derived growth factor (PDGF), angiostatin, and endostatin, which were related to angiogenesis, were chosen for further validation studies. Quantitative real-time reverse transcription polymerase chain reaction and western blot analysis validated that the levels of PDGF and ANG-2, which were related to pro-angiogenesis, were significantly increased in the PDRN group compared with those in the control group or the IL-1β group. However, the levels of endostatin and angiostatin, which were related in anti-angiogenesis, were significantly decreased in the PDRN group compared with those in the control group or the IL-1β group. In the same manner, vascular endothelial growth factor, which was a mediator of angiogenesis, was significantly increased in the PDRN group compared with those in the control group or the IL-1β group. Furthermore, wound closure was significantly increased in the PDRN group compared with the control group or the IL-1β group by in vitro scratch assay. Moreover, PDRN decreased expression of metalloproteinase 13, as a catabolic factor for OA, but increased expression of aggrecan, which was an anabolic factor for OA. These data suggest that PDRN may promote angiogenesis and wound healing via down-regulation of catabolism and up-regulation of anabolism in an in vitro model of OA.https://doi.org/10.1177/0963689718804130
spellingShingle Ahreum Baek
Yoon Kim
Jin Woo Lee
Sang Chul Lee
Sung-Rae Cho
Effect of Polydeoxyribonucleotide on Angiogenesis and Wound Healing in an Model of Osteoarthritis
Cell Transplantation
title Effect of Polydeoxyribonucleotide on Angiogenesis and Wound Healing in an Model of Osteoarthritis
title_full Effect of Polydeoxyribonucleotide on Angiogenesis and Wound Healing in an Model of Osteoarthritis
title_fullStr Effect of Polydeoxyribonucleotide on Angiogenesis and Wound Healing in an Model of Osteoarthritis
title_full_unstemmed Effect of Polydeoxyribonucleotide on Angiogenesis and Wound Healing in an Model of Osteoarthritis
title_short Effect of Polydeoxyribonucleotide on Angiogenesis and Wound Healing in an Model of Osteoarthritis
title_sort effect of polydeoxyribonucleotide on angiogenesis and wound healing in an model of osteoarthritis
url https://doi.org/10.1177/0963689718804130
work_keys_str_mv AT ahreumbaek effectofpolydeoxyribonucleotideonangiogenesisandwoundhealinginanmodelofosteoarthritis
AT yoonkim effectofpolydeoxyribonucleotideonangiogenesisandwoundhealinginanmodelofosteoarthritis
AT jinwoolee effectofpolydeoxyribonucleotideonangiogenesisandwoundhealinginanmodelofosteoarthritis
AT sangchullee effectofpolydeoxyribonucleotideonangiogenesisandwoundhealinginanmodelofosteoarthritis
AT sungraecho effectofpolydeoxyribonucleotideonangiogenesisandwoundhealinginanmodelofosteoarthritis